{"id":20968,"date":"2014-05-02T09:31:47","date_gmt":"2014-05-02T13:31:47","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=20968"},"modified":"2014-05-02T09:31:47","modified_gmt":"2014-05-02T13:31:47","slug":"johnson-johnson-nysejnj-halts-fibroids-device-sales","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968","title":{"rendered":"Johnson &#038; Johnson (NYSE:JNJ) Halts Fibroids Device Sales"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 05\/02\/2014 (wallstreetpr) &#8211;\u00a0<strong>Johnson &amp; Johnson (NYSE:JNJ)<\/strong>, engaged in R&amp;D, production and sale of a wide range of products in the health care field has decided to halt the sales of devices that are used to remove the growth in the uterus.<\/p>\n<p style=\"text-align: justify;\"><b>FDA issues advisory to doctors<\/b><\/p>\n<p style=\"text-align: justify;\">Food and Drug Administration has recently issued an advisory to doctors to avoid the use of laparoscopic power morcellators. The device is used by surgeons for the treatment of painful fibroids by removal of the growth or the whole uterus. The device helps to cut and remove the tissue using a blade. It helps to remove by making a small cut in the abdomen rather than a big opening made in the traditional surgery. The decision has been taken after the government issued a warning about the electronic surgical tools spreading cancer to other parts of the body.<\/p>\n<p style=\"text-align: justify;\"><b>Laparoscopic power morcellators can cause cancer<\/b><\/p>\n<p style=\"text-align: justify;\">According to the FDA, there is a great risk that the device can crush undetected uterine tumors and spread the cancer to the pelvis, abdomen and other regions. Hysterectomy is the leading treatment because it is the only way to ensure that fibroids do not return. Out of 600K women in the US undergoing hysterectomy, 50K use the power morcellation technique. The analysis shows that 1 out of every 350 women undergoing the fibroid procedure has been detected with the cancer called uterine sarcoma. Fibroids are non-cancerous growths that can cause severe pain, heavy bleeding, and bladder and bowel dysfunction in the uterus. Johnson &amp; Johnson has always cautioned the doctors about this risk.<\/p>\n<p style=\"text-align: justify;\"><b>A waiting game for Johnson &amp; Johnson <\/b><\/p>\n<p style=\"text-align: justify;\">Johnson &amp; Johnson (NYSE:JNJ)\u00a0is waiting for clarification from regulators and the medical community regarding morcellation and fibroid treatment as it is considered to be the best option for the patients. The FDA has called a meeting of its advisory committee to discuss the role of gynecological medical devices like laparoscopic power morcellation for the treatment of uterine fibroids. The sale, distribution and promotion of Gynecare Morcellex, Morcellex Sigma and Gynecare X-Tract devices will be temporarily suspended.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 05\/02\/2014 (wallstreetpr) &#8211;\u00a0Johnson &amp; Johnson (NYSE:JNJ), engaged in R&amp;D, production and sale of a wide range of products in the health care field [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":20971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[1744,995],"stock_ticker":[],"class_list":["post-20968","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-johnson-johnson-nysejnj","tag-nysejnj","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Johnson &amp; Johnson (NYSE:JNJ) Halts Fibroids Device Sales - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson &amp; Johnson (NYSE:JNJ) Halts Fibroids Device Sales - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 05\/02\/2014 (wallstreetpr) &#8211;\u00a0Johnson &amp; Johnson (NYSE:JNJ), engaged in R&amp;D, production and sale of a wide range of products in the health care field [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-05-02T13:31:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/download-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"393\" \/>\n\t<meta property=\"og:image:height\" content=\"81\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Van Bettauer\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Van Bettauer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968\"},\"author\":{\"name\":\"Van Bettauer\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\"},\"headline\":\"Johnson &#038; Johnson (NYSE:JNJ) Halts Fibroids Device Sales\",\"datePublished\":\"2014-05-02T13:31:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968\"},\"wordCount\":360,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/download-2.jpg\",\"keywords\":[\"Johnson &amp; Johnson (NYSE:JNJ)\",\"NYSE:JNJ\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968\",\"name\":\"Johnson & Johnson (NYSE:JNJ) Halts Fibroids Device Sales - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/download-2.jpg\",\"datePublished\":\"2014-05-02T13:31:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/download-2.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/download-2.jpg\",\"width\":393,\"height\":81},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson &#038; Johnson (NYSE:JNJ) Halts Fibroids Device Sales\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\",\"name\":\"Van Bettauer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"caption\":\"Van Bettauer\"},\"description\":\"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Johnson & Johnson (NYSE:JNJ) Halts Fibroids Device Sales - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968","og_locale":"en_US","og_type":"article","og_title":"Johnson & Johnson (NYSE:JNJ) Halts Fibroids Device Sales - Wall Street PR","og_description":"Boston, MA 05\/02\/2014 (wallstreetpr) &#8211;\u00a0Johnson &amp; Johnson (NYSE:JNJ), engaged in R&amp;D, production and sale of a wide range of products in the health care field [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-05-02T13:31:47+00:00","og_image":[{"width":393,"height":81,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/download-2.jpg","type":"image\/jpeg"}],"author":"Van Bettauer","twitter_misc":{"Written by":"Van Bettauer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968"},"author":{"name":"Van Bettauer","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d"},"headline":"Johnson &#038; Johnson (NYSE:JNJ) Halts Fibroids Device Sales","datePublished":"2014-05-02T13:31:47+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968"},"wordCount":360,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/download-2.jpg","keywords":["Johnson &amp; Johnson (NYSE:JNJ)","NYSE:JNJ"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968","url":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968","name":"Johnson & Johnson (NYSE:JNJ) Halts Fibroids Device Sales - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/download-2.jpg","datePublished":"2014-05-02T13:31:47+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/download-2.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/download-2.jpg","width":393,"height":81},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-halts-fibroids-device-sales-20968#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Johnson &#038; Johnson (NYSE:JNJ) Halts Fibroids Device Sales"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d","name":"Van Bettauer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","caption":"Van Bettauer"},"description":"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/20968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=20968"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/20968\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/20971"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=20968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=20968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=20968"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=20968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}